Crumly & Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,839
| Closed | -$450K | – | 107 |
|
|
2022
Q1 | $450K | Buy |
5,839
+91
| +2% | +$7.01K | 0.17% | 76 |
|
|
2021
Q4 | $505K | Buy |
5,748
+1,613
| +39% | +$142K | 0.2% | 71 |
|
|
2021
Q3 | $320K | Sell |
4,135
-2,624
| -39% | -$203K | 0.15% | 84 |
|
|
2021
Q2 | $564K | Sell |
6,759
-779
| -10% | -$65K | 0.27% | 59 |
|
|
2021
Q1 | $569K | Buy |
7,538
+3,446
| +84% | +$260K | 0.33% | 43 |
|
|
2020
Q4 | $360K | Sell |
4,092
-304
| -7% | -$26.7K | 0.25% | 46 |
|
|
2020
Q3 | $334K | Buy |
+4,396
| New | +$334K | 0.29% | 35 |
|